Inhibition of VP2-mediated entry: a potential antiviral strategy to treat or prevent calicivirus disease
Charlotte B. Lewis, Lee Sherry, Rochelle McGrory, Eibhlin Gould, Millie Freitag, Hágár Sasvári, June Southall, Filip Petrov, Amit Meir, Nithya Govindan, Andrea M. Spiri, Matteo Bordicchia, Regina Hofmann‐Lehmann, Vanessa R. Barrs, Joe Grove, , David Bhella
This study demonstrates that inhibiting VP2-mediated entry reduces calicivirus infectivity, suggesting a potential antiviral strategy for treating norovirus disease.
bioRxiv · May 15, 2026 · PreprintMicrobiology